ELEOPRA, ROBERTO

ELEOPRA, ROBERTO  

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale  

Mostra records
Risultati 1 - 20 di 23 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Up-regulation of tRNA-derived miR-1274b in tears of Parkinson's disease patients 2026 Eleopra, RobertoModa, Fabio + Article (author) -
Neuroimaging and Pathology Biomarkers in Parkinson’s Disease and Parkinsonism 2026 Angelo Del SoleRoberto EleopraFabio Moda + Article (author) -
Peripheral Biomarkers in α-Synucleinopathies: Unlocking Early Detection Through Olfactory Mucosa, Blood, and Urine Analysis 2025 Merve Begum BacınogluRoberto EleopraFabio Moda + Conference Object -
Detection of misfolded α-synuclein in the skin of patients with Parkinson’s disease and multiple system atrophy by seed amplification assay 2025 Merve Begum BacınogluRoberto EleopraFabio Moda + Conference Object -
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC Study 2025 Percetti, MarcoPriori, AlbertoEleopra, Roberto + Article (author) -
Chronic adaptive versus conventional deep brain stimulation in Parkinson’s disease: a blinded randomized pilot trial 2025 Isaias, Ioannis U.Marceglia, SaraBorellini, LindaMailland, EnricoCogiamanian, FilippoRemore, LuigiEleopra, RobertoLevi, VincenzoLocatelli, MarcoPriori, Alberto + Article (author) -
α-Synuclein distribution in olfactory mucosa and skin nerves in Parkinson disease associated with an EIF4G1 gene mutation 2025 Moda, FabioEleopra, Roberto + Article (author) -
Exploring NEK1 genetic variability in Italian amyotrophic lateral sclerosis patients 2025 Pensato V.Peverelli S.Tiloca C.Pingue M.Manini A.Tannorella P.Doretti A.Terenghi F.Verde F.Eleopra R.Taroni F.Lauria Pinter G.Silani V.Ticozzi N.Ratti A. + Article (author) -
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation 2025 Cocco A.Eleopra R.Monfrini E.Frattini E.Cogiamanian F.Arighi A.Cocco A.Boni L.Verde F.Triulzi F.Ticozzi N.Silani V.Ratti A.Poletti B.Caronni A.Baglio F.Moda F. + Article (author) -
Simultaneous MEG-LFP Recordings to Assess In Vivo Dystonic Neurophysiological Networks: A Feasibility Study 2025 Eleonora MinacapilliRoberto EleopraVincenzo Levi + Article (author) -
Are patients with GBA–Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 2024 Eleopra, RobertoMonfrini, Edoardo + Article (author) -
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment inGBA-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 2023 Moda, FabioEleopra, Roberto + Article (author) -
A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value 2022 Schindler, AntonioPizzorni, NicoleCereda, EmanueleEleopra, RobertoFerrari, ChiaraMasiero, Stefano + Article (author) -
Resting State Functional Connectivity Signatures of MRgFUS Vim Thalamotomy in Parkinson's Disease: A Preliminary Study 2022 Stanziano M.Rinaldo S.Ghielmetti F.Frazzetta G.DiMeco F.Eleopra R. + Article (author) -
A New Implantable Closed-Loop Clinical Neural Interface: First Application in Parkinson’s Disease 2021 Borellini L.Eleopra R.Rinaldo S.Priori A.Marceglia S. + Article (author) -
Functional motor phenotypes: to lump or to split? 2021 Eleopra R.Demartini B.Gambini O. + Article (author) -
Consensus on the treatment of dysphagia in Parkinson's disease 2021 Schindler, AntonioPizzorni, NicoleCereda, EmanueleEleopra, Roberto + Article (author) -
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study 2020 Barone P.Eleopra R.Demartini B.Gambini O.Di Stefano V. + Article (author) -
Diagnostic criteria for small fibre neuropathy in clinical practice and research 2019 Eleopra, RobertoLauria, Giuseppe + Article (author) -
Protein misfolding, amyotrophic lateral sclerosis and guanabenz : Protocol for a phase II RCT with futility design (ProMISe trial) 2017 R. EleopraV. SilaniG. LAURIA PINTER + Article (author) -